Combined Degenerative Mitral Valve and Coronary Surgery: Early Outcomes and 10-Year Survival

Vito D Bruno1, Mustafa Zakkar1, Gustavo Guida1

  • 1Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.

Insights

Combined degenerative mitral valve (DMV) and coronary artery bypass grafting (CABG) surgery shows similar outcomes to DMV surgery alone. Mitral valve repair in combined procedures improves long-term survival.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Disease
  • Coronary Artery Disease

Background:

  • Degenerative mitral valve (DMV) disease is a common cardiac condition.
  • Coronary artery disease (CAD) often coexists with DMV disease.
  • The optimal surgical approach for patients with both conditions requires investigation.

Purpose of the Study:

  • To compare the impact of combined coronary artery bypass grafting and degenerative mitral valve surgery (CABG+DMV) versus degenerative mitral valve surgery only (DMV-only).
  • To evaluate in-hospital outcomes and 10-year survival rates for these surgical approaches.
  • To assess the role of mitral valve repair in long-term survival.

Main Methods:

  • A retrospective analysis of 745 patients with DMV disease.
  • Comparison of 186 patients undergoing CABG+DMV surgery with 559 patients undergoing DMV-only surgery.
  • Propensity score-matching analysis to minimize bias and evaluate short-term composite outcomes and 10-year survival.

Main Results:

  • Combined CABG+DMV surgery demonstrated similar in-hospital composite endpoint rates compared to DMV-only surgery in both unmatched and matched analyses.
  • Ten-year survival rates were comparable between the combined surgery group and the DMV-only group.
  • Mitral valve repair was associated with improved short-term outcomes and long-term survival, irrespective of concomitant coronary surgery.

Conclusions:

  • Combined CABG+DMV surgery is an effective treatment option for patients with concomitant coronary and degenerative mitral valve disease.
  • Early and long-term survival outcomes are comparable between combined surgery and DMV-only surgery.
  • Mitral valve repair is a critical factor for enhancing long-term survival in patients undergoing combined procedures.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
182
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
274
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
297
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
199
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
252
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
290